Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|July 16, 2008
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancerMarjorie Zauderer, Sujata Patil, Arti Hurria
Annals of Surgical Oncology|April 22, 2017
Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast CancerAnita Mamtani, Sujata Patil, Michelle Stempel, et al.
Work (Reading, Mass.)|March 7, 2022
Vulnerabilities in workplace features for essential workers with breast cancer: Implications for the COVID-19 pandemicMadelyn Klugman, Sujata Patil, Francesca Gany, et al.
Annals of Surgical Oncology|June 22, 2014
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementStacy Ugras, Michelle Stempel, Sujata Patil, et al.
Cancer|March 24, 2017
Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?Anita Mamtani, Sujata Patil, Michelle M Stempel, et al.
Cancer|November 19, 2009
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretationSujata Patil, Nicole Ishill, John Deluca, et al.
Scientific Reports|July 7, 2025
Smart adaptive learning and optimized feature clustering for enhanced image retrievalP Umaeswari, Sujata Patil, Parameshachari Bidare Divakarachari, et al.
Expert Review of Anticancer Therapy|December 7, 2013
Brain metastases in breast cancerHao-Wen Sim, Patrick G Morris, Sujata Patil, et al.
Annals of Surgical Oncology|April 2, 2021
Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal AdenocarcinomaSeth I Felder, Sujata Patil, Erin Kennedy, et al.
Annals of Surgical Oncology|November 3, 2016
Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?Melissa Pilewskie, Cristina Olcese, Sujata Patil, et al.
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|July 16, 2008
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancerMarjorie Zauderer, Sujata Patil, Arti Hurria
Annals of Surgical Oncology|April 22, 2017
Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast CancerAnita Mamtani, Sujata Patil, Michelle Stempel, et al.
Work (Reading, Mass.)|March 7, 2022
Vulnerabilities in workplace features for essential workers with breast cancer: Implications for the COVID-19 pandemicMadelyn Klugman, Sujata Patil, Francesca Gany, et al.
Annals of Surgical Oncology|June 22, 2014
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementStacy Ugras, Michelle Stempel, Sujata Patil, et al.
Cancer|March 24, 2017
Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?Anita Mamtani, Sujata Patil, Michelle M Stempel, et al.
Cancer|November 19, 2009
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretationSujata Patil, Nicole Ishill, John Deluca, et al.
Scientific Reports|July 7, 2025
Smart adaptive learning and optimized feature clustering for enhanced image retrievalP Umaeswari, Sujata Patil, Parameshachari Bidare Divakarachari, et al.
Expert Review of Anticancer Therapy|December 7, 2013
Brain metastases in breast cancerHao-Wen Sim, Patrick G Morris, Sujata Patil, et al.
Annals of Surgical Oncology|April 2, 2021
Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal AdenocarcinomaSeth I Felder, Sujata Patil, Erin Kennedy, et al.
Annals of Surgical Oncology|November 3, 2016
Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?Melissa Pilewskie, Cristina Olcese, Sujata Patil, et al.
Pageof 23